Saturday | December 03, 2022 |
Market Status: CLOSED

Market News

Med Life S.A. - M

Completion of Veridia Medical Center acquisition

Release Date: 3/5/2021 12:47:29 PM

IRIS Code: 9546E


MedLife Medical System has completed the acquisition of Veridia Medical Center



Buharest, March 5, 2021: MedLife Medical System announces the completion of the transaction for the purchase of the full shareholding package of Veridia Medical Center in Bucharest, known as Basarab Medical Center.


Veridia Medical Center has been operating on the private medical services market for 17 years, being a traditional player in Bucharest. It has started its activity with a medical analysis laboratory and later on consolidated its position by developing a large medical center that incorporates 20 medical offices and which provides specialized medical services, general medicine consultations and consultations of different specialties, paraclinical investigations, treatments and minor surgeries. Additionally, for sampling for laboratory testing, the center also includes four sampling points, located in Berceni, Militari, Drumul Taberei and Pantelimon neighborhoods.


Since the beginning of September 2020, Veridia Medical Center, through the molecular biology laboratory, is in partnership with the Directorate of Public Health (DSP) for RT-PCR testing, designed to detect SARS-CoV-2 virus, with a capacity of 400 samples per day.


At the same time, Veridia is one of the relevant providers of medical services under contract with the Health Insurance House of Bucharest (CASMB), covering over 25 specialties, including allergology, ENT, endocrinology, obstetrics-gynecology, pediatrics, cardiology, pneumology, gastroenterology and neurology. For the corporate segment, the medical center plays an important role, as it provides occupational health services to companies.



About MedLife:


MedLife is the largest provider of private healthcare services in Romania. The company operates the largest network of clinics, one of the largest networks of medical laboratories, mono and multidisciplinary hospitals and has the largest customer base for Health Prevention Packages in the country. It is also one of the largest private healthcare providers in Central and Eastern Europe in terms of sales.


The shares issued by MedLife SA are admitted to trading on the regulated spot market administered by the Bucharest Stock Exchange, Premium Category, with the trading symbol ″ M ″.


MedLife Group has a succesflul history in terms of both organic growth and growth by acquisitions. Since 2009 it has opened or acquired more than 150 medical units. Strong and experienced management team, has been able to create and manage these growth opportunities, gaining valuable knowledge and experience that will support the group to successfully continue the expansion.



Information provided by IRIS, the news platform of the Bucharest Stock Exchange.


Bucharest Stock Exchange ("BVB") is not responsible for the content of this News item. Issuers whose financial instruments are traded on markets operated by BVB are required to report in accordance with current legal and regulatory provisions. BVB publishes these Reports as market administrator, appointed by ASF. When, for investors’ information, Reports are published, either signed by different persons, or with conflicting information, legal liability lies fully with the signatories. BVB disclaims any obligation or responsibility towards issuers or third parties, regarding the reality, completeness and accuracy of information provided by them and distributed by BVB. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

©2016 Bucharest Stock Exchange. All rights reserved